Gene therapy platform AskBio snags $235 mln
North Carolina-based AskBio, a gene therapy platform, has secured $235 million in funding. The investors included TPG Capital and Vida Ventures.
11 April 2019•1 min read
North Carolina-based AskBio, a gene therapy platform, has secured $235 million in funding. The investors included TPG Capital and Vida Ventures.
